Meiqin Liu

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin, Xiaoyu Du, Yechun Xu et al. · Nature · 2020 · 4.5K citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +10

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Shuai Xia, Meiqin Liu, Chao Wang et al. · Cell Research · 2020 · 1.4K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Shuai Xia, Yun Zhu, Meiqin Liu et al. · Cellular and Molecular Immunology · 2020 · 758 citations · Full text

Life Sciences, Biomedical Sciences, Molecular Biology +10

Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 732 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Chunyan Yi, Xiaoyu Sun, Jing Ye et al. · Cellular and Molecular Immunology · 2020 · 544 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13